WonTae Park - Bukwang Pharm Managing Director
| 003000 Stock | 4,860 215.00 4.63% |
Managing Director
WonTae Park is Managing Director of Bukwang Pharm
| Age | 71 |
| Phone | 82 2 828 8114 |
| Web | https://www.bukwang.co.kr |
Bukwang Pharm Management Efficiency
Bukwang Pharm's management efficiency ratios could be used to measure how well Bukwang Pharm manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 2 records | MANAGING DIRECTOR Age | ||
| HeeWuk Kim | Hankukpackage Co | 67 | |
| BooHo Lee | Hankukpackage Co | 70 | |
Management Performance
| Return On Equity | -0.0168 | |||
| Return On Asset | 0.0024 |
Bukwang Pharm Leadership Team
Elected by the shareholders, the Bukwang Pharm's board of directors comprises two types of representatives: Bukwang Pharm inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bukwang. The board's role is to monitor Bukwang Pharm's management team and ensure that shareholders' interests are well served. Bukwang Pharm's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bukwang Pharm's outside directors are responsible for providing unbiased perspectives on the board's policies.
| WonTae Park, Managing Director | ||
| HeeSang Lee, Managing Director | ||
| GeumSeo Gu, Managing Director | ||
| YoungChoon Lee, Managing Director | ||
| SungGu Lee, Pres Officer | ||
| IlTae Kim, Managing Director | ||
| TaeHyun Kim, VP Director | ||
| SangHoon Kim, Head Director | ||
| Yoo HuiWon, Chief Director | ||
| JongMoon Kim, Managing Director |
Bukwang Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bukwang Pharm a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.0168 | |||
| Return On Asset | 0.0024 | |||
| Profit Margin | (0.01) % | |||
| Operating Margin | 0.01 % | |||
| Current Valuation | 552.14 B | |||
| Shares Outstanding | 68.45 M | |||
| Shares Owned By Insiders | 30.26 % | |||
| Shares Owned By Institutions | 8.04 % | |||
| Price To Book | 2.45 X | |||
| Price To Sales | 3.55 X |
Pair Trading with Bukwang Pharm
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bukwang Pharm position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bukwang Pharm will appreciate offsetting losses from the drop in the long position's value.Moving together with Bukwang Stock
| 0.7 | 005930 | Samsung Electronics | PairCorr |
| 0.69 | 005935 | Samsung Electronics | PairCorr |
| 0.69 | 005385 | Hyundai Motor | PairCorr |
| 0.62 | 005387 | Hyundai Motor | PairCorr |
| 0.82 | 005380 | Hyundai Motor | PairCorr |
Moving against Bukwang Stock
| 0.35 | 373220 | LG Energy Solution | PairCorr |
| 0.35 | 105560 | KB Financial Group | PairCorr |
| 0.33 | 024110 | Industrial Bank | PairCorr |
The ability to find closely correlated positions to Bukwang Pharm could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bukwang Pharm when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bukwang Pharm - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bukwang Pharm to buy it.
The correlation of Bukwang Pharm is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bukwang Pharm moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bukwang Pharm moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bukwang Pharm can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in Bukwang Stock
Bukwang Pharm financial ratios help investors to determine whether Bukwang Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bukwang with respect to the benefits of owning Bukwang Pharm security.